Ayuda
Ir al contenido

Dialnet


Resumen de Quadrivalent Human Papillomavirus Vaccine and the Risk of Venous Thromboembolism

Nikolai Madrid Schelle, Björn Pasternak

  • A potential association between quadrivalent human papillomavirus (HPV) vaccination and venous thromboembolism (VTE) has been reported in 2 postlicensure safety studies.1,2 An analysis of the Vaccine Adverse Event Reporting System database found disproportionately high reporting of VTE following vaccination,1 and a study using the Vaccine Safety Datalink reported a doubling of VTE risk.2


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus